At 11.9x earnings and 10.7x forward earnings, CTBI screens optically cheap, but the valuation discount is not screamingly mispriced given a 2.1 forward PEG and a deeply troubling Altman Z-Score of 0.4. The market is pricing this as a slow-growth regional bank with balance sheet fragility risk, not as a compounder. A 4.30% ROE and 11.50% operating margin are underwhelming for a bank trading at 1.4x book, suggesting mediocre capital efficiency. The forward multiple implies mild earnings expansion, but the distress signal from the Z-Score keeps this firmly in “cautious value” territory rather than high-conviction deep value.